ASCO GU Conference Coverage
Featured Articles
(Medscape Medical News) Feb 17, 2017 - For the first time in decades, there is a major advance in the second-line treatment of patients with advanced urothelial carcinoma whose disease has recurred or progressed after initial chemotherapy, according to new trial results published today in the New England Journal of Medicine.
Read Article
(Genentech) Feb 17, 2017 - Genentech, a member of the Roche Group, today announced encouraging results from the Phase II IMmotion150 study that compared TECENTRIQ® (atezolizumab) plus Avastin® (bevacizumab) and TECENTRIQ monotherapy to sunitinib alone in people with previously untreated, locally advanced or metastatic renal cell...
Read Article
Latest Articles
February 22, 2017
February 21, 2017
February 21, 2017
February 21, 2017
February 21, 2017
February 17, 2017
February 17, 2017
February 16, 2017
View More
News Commentary
There is no ASCO GU Conference Coverage commentary.

OBR Green
There are no ASCO GU Conference Coverage OBR Green articles.
OBR Blog
The 2017 Genitourinary Cancers Symposium takes place in Orlando, FL, on February 16 – 18, and a press cast held in... Read more
February 13, 2017